openPR Logo
Press release

Hemorrhage Control System Market Strategies and Forecasts, 2016 to 2026

06-27-2016 09:58 AM CET | Health & Medicine

Press release from: Future Market Insights

Hemorrhage Control System Market Strategies and Forecasts,

Bleeding is the leading cause of death in almost all types of traumatic injuries. Also it has been noted that stopping haemorrhage early can prevent death in almost 90% of cases. However many trauma patients arriving late to the hospitals develops coagulopathy.

Haemorrhage Control System are devices designed to halt severe bleeding from open wounds, during injury especially in situations where tourniquets and haemostatic agents such as bandages and wound dressings are not effective. The device is effective in sealing the edges of a wound to create a temporary hematoma under pressure that lessens blood loss before surgery.

Haemorrhage control systems create mechanical direct pressure i.e. pressure outside the bleeding vessel which neutralises pressure inside the bleeding vessel and results in haemostasis.

Haemorrhage control systems market comprises of the devices, used during emergency situations, which helps to stop bleeding.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1635

The main factor driving the growth of haemorrhage control system testing market is increasing number of traumatic battlefield injury. Also, the growth of haemorrhage control system market is attributed to government approval for marketing the product in different regions. Secondly increased usage of the device for military medical applications also drives the market for haemorrhage control systems. However apart from the factors leading to the growth of this market, there are some restraints hampering the market growth over the forecast period for example lower awareness regarding haemorrhage control systems, reluctance to use the devices during emergency due to fear of causing additional trauma.

On the basis of region presence, haemorrhage control systems marketis segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1635

The rapid development in technology, increasing healthcare expenditure and willingness to adopt innovative products for emergency care are some of the key factors projected to drive the growth of haemorrhage control systems market globally during the forecast period. North America holds a major share of market and it is expected to grow with a healthy CAGR over the forecast period, due to increased government spending for emergency first aid products for military application. Whereas Asia pacific is projected to grow with the fastest CAGR due to factors such as increased healthcare spending for emergency medical applications and rising number of trauma cases. Haemorrhage control systems market in Western Europe is also anticipated to grow with a decent CAGR, due to changing government norms in some countries.

Main Key market players in the global hemorrhage control systems includes RevMedx, Inc., iTraumaCare and few more. Whereas global hemorrhage control systems market is expected to witness entry of local players within this market.

Browse Full Report@ http://www.futuremarketinsights.com/reports/hemorrhage-control-system-market

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemorrhage Control System Market Strategies and Forecasts, 2016 to 2026 here

News-ID: 345971 • Views:

More Releases from Future Market Insights

Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% CAGR and Rising Demand for Carotenoids and Omega Compounds
Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% …
The global eye health ingredients industry is projected to reach USD 360.3 million by 2035, expanding from USD 174.8 million in 2025 at a CAGR of 7.5%. Growth is fueled by increasing consumer awareness around preventive eye health, heavy screen exposure, and rising age-related vision issues. As consumers adopt nutraceuticals, fortified foods, and ocular supplements, demand for carotenoids, omega-based compounds, and botanical extracts continues to scale across retail and healthcare
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million by 2035
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million …
The global grapeseed oil market is projected to grow from USD 541.5 million in 2025 to USD 809.3 million by 2035, registering a CAGR of 4.1%. Rising demand across culinary, personal care, and nutraceutical applications is elevating its market value due to its rich antioxidant profile, vitamin E content, and plant-based origin. Health-conscious consumers are increasingly choosing grapeseed oil for premium cooking and natural skincare, while manufacturers expand cold-pressing capacities to
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by 7.8% CAGR
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by …
The global soybean enzymatic protein market is moving into a phase of rapid commercial adoption, projected to expand from USD 2.4 billion in 2025 to USD 5.2 billion by 2035, registering a CAGR of 7.8%. What began as a niche application segment during 2020-2024 has now matured into a scalable, mainstream protein category integrated into beverages, functional foods, meat alternatives, and nutritional supplements. Between 2025 and 2030, the market enters its
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growth
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growt …
The global squid market, valued at USD 12.7 billion in 2025, is projected to reach USD 18.4 billion by 2035, reflecting a 3.8% CAGR, driven by rising seafood demand, diversified product formats, and robust food supply chains. Steady consumption growth across Asia-Pacific, Europe, and North America continues to uplift commercial fishing, aquaculture, and value-added squid processing. Growth momentum between 2021 and 2025 shows a consistent upward curve, with the market expanding

All 5 Releases


More Releases for Haemorrhage

Adult Intraventricular Haemorrhage (IVH) Market Strengthens with Advanced Neuroc …
The Adult Intraventricular Haemorrhage (IVH) market is evolving from basic ventricular drainage and supportive care into a more technology-driven neurocritical care segment. As stroke centres scale up, use of standardised EVD protocols, multimodality neuromonitoring, intraventricular thrombolysis, and minimally invasive endoscopic or catheter-based evacuation grows, creating incremental demand for high-quality neurosurgical devices and critical-care services worldwide. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72104 Keyword definition Adult intraventricular haemorrhage (IVH) refers to
Adult Intraventricular Haemorrhage Market Massive Growth opportunity Ahead
Introduction Adult Intraventricular Haemorrhage (IVH) is a severe neurological condition involving bleeding into the brain's ventricular system. While commonly associated with premature infants, IVH in adults often results from trauma, aneurysm rupture, stroke, or complications from neurosurgical procedures. It is a life-threatening emergency that requires immediate intervention and long-term rehabilitation. The increasing burden of stroke, traumatic brain injuries, and vascular abnormalities is fueling demand for advanced neurosurgical tools, critical care monitoring, and
A consortium led by Hemostatics receives €2.5 M to validate a revolutionary th …
A public-private consortium formed by the biotech Hemostatics, based at the Barcelona Science Park, the Clínica Universidad de Navarra (CUN) and the Institut Català d'Investigació Química (ICIQ), has received 2.5 million euros from AEI, the State Investigation Agency, under the call for grants for Public-Private Collaboration Projects, to accelerate the development of an innovative treatment aimed at controlling disabling and lethal haemorrhage. The aim of the project, led by Hemostatics -
Postpartum Haemorrhage Treatment Device Market to reach USD 1.66 Bn with a Compo …
Postpartum Haemorrhage Treatment Device Market Report Scope and Research Methodology The Postpartum Haemorrhage Treatment Device Market report by Maximize Market Research Pvt Ltd provides a comprehensive and in-depth analysis of the global market. It covers various aspects of the market, including market size, growth trends, drivers, restraints, and opportunities. The report segments the market based on types, applications, and regions, offering valuable insights into each segment's performance and potential. Moreover, the
Postpartum Haemorrhage (PPH) Treatment Device Market to Witness Huge Growth by K …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Postpartum Haemorrhage (PPH) Treatment Device industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Postpartum Haemorrhage (PPH) Treatment Device market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Postpartum Haemorrhage
Oxytocic Pharmaceuticals Market: Labour Induction During Childbirth is Likely to …
Though synthetic oxytocin is chemically equivalent to naturally-occurring oxytocin, their pharmaceutical functions for aiding women in labour are quite distinctive. Medical professionals from around the world will continue to recommend synthetic-based oxytocic pharmaceuticals over natural since oxytocic pharmaceuticals originating from synthetic sources can boost the momentum of decelerated labour by IV administration. More than 90% of the global market revenues for oxytocic pharmaceuticals will be harvested from the sales of